Immunodiagnostic Systems Hldgs (LON:IDH) , the specialist in vitro diagnostic testing company, released a trading update at its AGM on the 25th of August. The company reported that trading was in line with management expectations and that demand for both its manual diagnostic tests and its IDS-iSYS automatic assay system remains strong. The company also announced that it has won its first two accounts for the IDS-iSYS system in the US, which should provide a combined annual income of c. $500,000. The company has placed a total 41 IDS-iSYS systems since the beginning of the current fiscal year (115 since launch).

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here